This was a descriptive non-interventional study in HIV-1-infected patients treated with DRV/r conducted in the clinical setting, with a single-arm prospective design. The primary objective was to collect data on utilization of darunavir/ritonavir (DRV/r) under the conditions described in the marketing authorization. Efficacy (measured as viral load [VL] <50 copies/mL and CD4+ cell count) was evaluated for DRV/r in combination with other antiretroviral (ARV) agents in routine clinical practice in Italy.
Effectiveness and durability of darunavir/ritonavir (DRV/r) in DRV/r-experienced HIV-1-infected patients in routine clinical practice / A. Antinori, M. Galli, N. Gianotti, C. Mussini, T. Quirino, K. Sterrantino, D. Mancusi, R. Termini. - In: JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. - ISSN 1758-2652. - 17:4 suppl. 3(2014 Nov 02), pp. 19786.1-19786.2. ((Intervento presentato al convegno International Congress of Drug Therapy in HIV Infection tenutosi a Glasgow nel 2014 [10.7448/IAS.17.4.19786].
Effectiveness and durability of darunavir/ritonavir (DRV/r) in DRV/r-experienced HIV-1-infected patients in routine clinical practice
M. GalliSecondo
;
2014
Abstract
This was a descriptive non-interventional study in HIV-1-infected patients treated with DRV/r conducted in the clinical setting, with a single-arm prospective design. The primary objective was to collect data on utilization of darunavir/ritonavir (DRV/r) under the conditions described in the marketing authorization. Efficacy (measured as viral load [VL] <50 copies/mL and CD4+ cell count) was evaluated for DRV/r in combination with other antiretroviral (ARV) agents in routine clinical practice in Italy.
| File | Dimensione | Formato | |
|---|---|---|---|
|
19786-14773-1-PB.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
80.85 kB
Formato
Adobe PDF
|
80.85 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
